Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Hematology (Amsterdam, Netherlands)
|
July 14, 2016
Macrophage Inflammatory Protein-1 Alpha: A Paradox?
A N Parker, I B Pragnell
Blood Reviews
|
December 1, 1995
Inhibitors of haemopoiesis and their potential clinical relevance
A N Parker, I B Pragnell
Clinical and Laboratory Haematology
|
July 29, 2004
Fatal peripheral neuropathy following FLA chemotherapy
W L Osborne, T L Holyoake, I G McQuaker, et al.
British Journal of Haematology
|
July 1, 1992
Effective treatment of relapsed acute myeloid leukaemia with drugs chosen by DiSC assay
A N Parker, R M Hutchinson, C S Chapman, et al.
Bone Marrow Transplantation
|
July 25, 2007
Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss
P S Maclean, A N Parker, I G McQuaker, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Synthesis and structure-DNA binding relationship analysis of DNA triple-helix specific intercalators
L Strekowski, Y Gulevich, T C Baranowski, et al.
Bone Marrow Transplantation
|
September 11, 2001
Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant
J D Robertson, N G Testa, N H Russell, et al.
Blood
|
June 1, 1996
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow
T L Holyoake, M G Freshney, L McNair, et al.
Bone Marrow Transplantation
|
January 11, 2005
A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients
N E Jordanides, E K Allan, L A McLintock, et al.
Bone Marrow Transplantation
|
March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA
K W Douglas, A N Parker, P J Hayden, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Hematology (Amsterdam, Netherlands)
|
July 14, 2016
Macrophage Inflammatory Protein-1 Alpha: A Paradox?
A N Parker, I B Pragnell
Blood Reviews
|
December 1, 1995
Inhibitors of haemopoiesis and their potential clinical relevance
A N Parker, I B Pragnell
Clinical and Laboratory Haematology
|
July 29, 2004
Fatal peripheral neuropathy following FLA chemotherapy
W L Osborne, T L Holyoake, I G McQuaker, et al.
British Journal of Haematology
|
July 1, 1992
Effective treatment of relapsed acute myeloid leukaemia with drugs chosen by DiSC assay
A N Parker, R M Hutchinson, C S Chapman, et al.
Bone Marrow Transplantation
|
July 25, 2007
Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss
P S Maclean, A N Parker, I G McQuaker, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Synthesis and structure-DNA binding relationship analysis of DNA triple-helix specific intercalators
L Strekowski, Y Gulevich, T C Baranowski, et al.
Bone Marrow Transplantation
|
September 11, 2001
Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant
J D Robertson, N G Testa, N H Russell, et al.
Blood
|
June 1, 1996
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow
T L Holyoake, M G Freshney, L McNair, et al.
Bone Marrow Transplantation
|
January 11, 2005
A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients
N E Jordanides, E K Allan, L A McLintock, et al.
Bone Marrow Transplantation
|
March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA
K W Douglas, A N Parker, P J Hayden, et al.
Page
of 2